LETROZOLE TABLETS
Categories:,
LETROZOLE TABLETS

Download as PDF
Enquire Now

Description

PRODUCT DESCRIPTION:

 

Letrozole is a potent non-steroidal aromatase inhibitor indicated primarily in hormone-sensitive conditions. It works by lowering estrogen levels in the body, thereby slowing or reversing the growth of estrogen-dependent tumors.

Widely used in breast cancer management and assisted reproductive therapies, Letrozole plays a key role in modern endocrinological and fertility care.

Formulation & Presentation:

  • Dosage Form: Oral Tablets
  • Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
  • Available Strengths: 2.5 MG/ 5 MG Tablets

Route of Administration:

  • Oral (As per clinical therapeutic indication and treatment protocol)

Therapeutic Indications:

  • Hormone receptor-positive breast cancer in postmenopausal women
  • Ovulation induction in infertility treatment protocols
  • Adjuvant and extended adjuvant treatment of early breast cancer
  • Advanced breast cancer as second-line therapy

Side Effects:

  • COMMON: Hot flashes, fatigue, dizziness, nausea, and musculoskeletal pain
  • SERIOUS (RARE): Osteoporosis, increased cholesterol levels, cardiovascular risks, and liver function abnormalities
  • PRECAUTIONS: Caution in patients with hepatic impairment
    • Not indicated in premenopausal women unless under fertility protocols
    • Baseline bone density and lipid profile monitoring is advised during prolonged therapy

Reviews

There are no reviews yet.

Be the first to review “LETROZOLE TABLETS”

Your email address will not be published. Required fields are marked *

12345

TECHNICAL INFORMATION

Product Specifications:

  • HSN Code: 30049099
  • Weight: Approx. 40g per Carton (With Packaging)
  • Dimensions: 15x1x8 CMS
  • Shelf Life (Subject To Country Specific Guidelines): 24 months from date of manufacture
  • Storage: Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight

Regulatory Status & Supply Information:

  • Regulatory Status: USFDA/WHO-GMP Complaint Manufacturing. Further certifications available on request
  • Exports Ready Dossiers: Dossier Available (CTD/eCTD formats)
  • Stability: Zone IVB Compliant
  • MOQ: Negotiable. Based on market & registration status
  • Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

  • Oncology & IVF specialists and women’s health clinics
  • Distributors dealing in fertility and hormonal therapies
  • National breast cancer programs or women’s health initiatives in LMICs
  • Tender authorities seeking oral hormonal modulators
  • Letrozole is a high-demand molecule with cross-functional utility in oncology and fertility

Why Source from PHARMET?

  • Single-window sourcing for diverse pharma needs
  • Export-ready documentation & regulatory support
  • Adaptable documentation support for effective registration
  • Trusted consortium network simplifying India’s pharma supply chain
  • Multiple approved manufacturers to fit import requirements
  • Network of audited, compliant manufacturers across India
  • Customizable branding, packaging & formulation flexibility
  • End to End logistics support & coordination
  • Expertise in exporting specialty injectables & ART products

CONTACT DETAILS:

Related items